Furthermore, baicalein preserved the BLM-induced downregulation of lung Sirt3 expression, and thus the suppression of TGF-β1/Smad signalling pathway and lung fibrosis, which might provide an experimental basis for treatment of IPF (Figure 8). The gene discussed is TGFB1; the disease is pulmonary fibrosis.